What is Oceanaa Biotek Industries share price return in the past 10 years?

Oceanaa Biotek Industries Ltd share price has declined -9.8% annually (CAGR) over the past ten years.

What is the P/E ratio of Oceanaa Biotek Industries?

The latest standalone P/E ratio of Oceanaa Biotek Industries as of 23-May-2022 is 0.00.

What is the P/B ratio of Oceanaa Biotek Industries?

The latest standalone P/B ratio of Oceanaa Biotek Industries as of 23-May-2022 is 0.12.

What is the 52-week high and low of Oceanaa Biotek Industries?

The 52-week high of Oceanaa Biotek Industries is Rs. 2.64 and the 52-week low is Rs. 2.40.

Oceanaa Biotek Industries Ltd - Stock Valuation and Financial Performance

Name: Oceanaa Biotek Industries
Brand: Oceanaa Biotek Industries

BSE: 538019 | NSE: | Aquaculture | Small Cap

Place order

DeciZen - make an informed investing decision on Oceanaa Biotek

Based on:

Data

M-Cap below 100cr DeciZen not available

Oceanaa Biotek Industries stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

3.3 Cr.

52-wk low:

2.4

52-wk high:

2.6

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Oceanaa Biotek Industries Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Oceanaa Biotek:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	TTM
ROCE % ⓘ	0%	0%	2.8%	13.6%	16.7%	32.6%	31.9%	57.2%	-56%	9.5%	-
Value Creation Index ⓘ	NA	NA	-0.8	0.0	0.2	1.3	1.3	3.1	-5.0	-0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0.3	6.7	46.5	32.1	36.5	60.5	36.3	25.7	22
Sales YoY Gr.	-	NA	3,300%	1,873.5%	592.3%	-30.8%	13.5%	65.8%	-40%	-29.3%	-
Adj EPS ⓘ	-12.5	-8.4	0.1	0.5	0.9	2.2	2.7	8.1	-12.1	1.6	-1.1
YoY Gr.	-	NA	NA	940%	73.1%	148.9%	20.5%	198.5%	-249.8%	NA	-
BVPS (₹) ⓘ	-49.5	-45.1	5.8	6.2	10	11.7	14.8	33.4	18.6	20.3	20.1
Adj Net Profit ⓘ	0	0	0	0.5	0.9	2.3	2.8	10.9	-16.4	2.2	-1
Cash Flow from Ops. ⓘ	0	0	0	-0.1	2	1.1	0.5	1.7	-5.3	6.8	-
Debt/CF from Ops. ⓘ	0	0	0	0	0.1	0.1	0.1	0.8	-0.2	0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-11.2%	-11%	-29.3%
Adj EPS ⓘ	NA	12.6%	-15.5%	NA
BVPSⓘ	NA	15.1%	11%	8.8%
Share Price	-9.8%	-27.4%	-6%	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	TTM
Return on Equity % ⓘ	40.9	24.1	1.9	10.7	11.7	20.6	20.3	36.3	-46.4	8.4	-5.3
Op. Profit Mgn % ⓘ	0	-111.6	12.2	11.2	4.5	16	14.8	34.8	-34.8	18.5	5.6
Net Profit Mgn % ⓘ	0	-143.5	8.4	6.9	2	7.1	7.6	18.1	-45.1	8.6	-6.7
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	26	1,703	291	53	102	141	156	292	301	182
Cash Conv. Cycle ⓘ	0	0	75	-2	10	28	30	48	104	40	75

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Oceanaa Biotek Industries Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-1.1	0
TTM Sales (₹ Cr.)	21.6	0
BVPS (₹.) ⓘ	20.1	10
Reserves (₹ Cr.) ⓘ	14	-
P/BV ⓘ	0.12	0.26
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	2.40 / 2.64
All Time Low / High (₹)	2.15 / 187.20
Market Cap (₹ Cr.)	3.3
Equity (₹ Cr.)	13.6
Face Value (₹)	10
Industry PE ⓘ	45.7

Management X-Ray of Oceanaa Biotek:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Oceanaa Biotek

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Oceanaa Biotek

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Sales	0	0.01	0.34	6.71	46.45	32.13	36.45	60.45	36.28	25.65
Operating Expenses ⓘ	0.02	0.02	0.30	5.96	44.34	27	31.06	39.43	54.18	20.92
Manufacturing Costs	0	0	0	0.09	1.23	4.15	4.45	5.42	3.11	1.33
Material Costs	0	0	0.08	5.32	41.39	18.54	21.07	29.77	32.33	10.43
Employee Cost	0	0	0.18	0.36	0.67	1.40	1.88	2.08	1.93	1.31
Other Costs ⓘ	0.02	0.02	0.04	0.18	1.05	2.91	3.66	2.15	16.81	7.86
Operating Profit ⓘ	-0.02	-0.01	0.04	0.75	2.11	5.14	5.39	21.02	-17.90	4.74
Operating Profit Margin (%)	-	-111.0%	12.2%	11.2%	4.5%	16.0%	14.8%	34.8%	-49.3%	18.5%
Other Income ⓘ	0	0	0	0	0	0	0.04	0.08	0.01	0.03
Interest ⓘ	0	0	0	0.01	0.06	0.11	0.04	0.72	0.17	0.10
Depreciation ⓘ	0	0	0	0.01	0.63	1.34	1.10	3.46	2.50	2.17
Exceptional Items ⓘ	0	0	0	-0.16	-0.16	-0.15	0	0	0	0
Profit Before Tax ⓘ	-0.02	-0.01	0.04	0.58	1.27	3.53	4.30	16.91	-20.57	2.49
Tax ⓘ	0	0	0.01	0.23	0.46	1.36	1.55	5.97	-0.51	0.28
Profit After Tax	-0.02	-0.01	0.03	0.35	0.81	2.18	2.75	10.94	-20.05	2.22
PAT Margin (%)	-	-143.0%	8.4%	5.2%	1.7%	6.8%	7.5%	18.1%	-55.3%	8.6%
Adjusted EPS (₹)	-12.5	-8.4	0.1	0.4	0.8	2.1	2.7	8.1	-14.8	1.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	17%	22%	19%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Equity and Liabilities
Shareholders Fund	-0.06	-0.08	3.06	5.51	10.22	11.97	15.09	45.24	25.26	27.48
Share Capital ⓘ	0.01	0.01	3.12	5.22	6	6	10.20	13.57	13.57	13.57
Reserves ⓘ	-0.07	-0.09	-0.06	0.29	4.22	5.97	4.89	31.68	11.70	13.92
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0.12	0.07	0.04	1.28	1.03	0.75
Long Term Debt	0	0	0	0	0	0	0	1.28	1.03	0.75
Short Term Debt	0	0	0	0	0.12	0.07	0.04	0	0	0
Trade Payables	0.09	0	0.03	3.83	2.52	5.05	4.31	3.64	3.75	3.55
Others Liabilities ⓘ	0	0.08	0.24	0.35	0.55	2.27	2.87	10.26	9.16	9.24
Total Liabilities ⓘ	0.02	0.01	3.32	9.68	13.42	19.37	22.31	60.42	39.19	41.03
Fixed Assets
Gross Block	0	0	0.04	0.04	8.12	8.74	8.89	30.92	24.48	30.98
Accumulated Depreciation	0	0	0	0.01	0.63	1.97	3.08	6.54	7.82	9.98
Net Fixed Assetsⓘ	0	0	0.04	0.03	7.48	6.76	5.81	24.38	16.66	21
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0.05	0	0	0	0
Inventories	0	0	0.17	0	0	4.73	4.91	6.42	0.54	0.75
Trade Receivables	0	0	0.01	4.22	5.08	2.55	4.86	10.82	10.61	5.27
Cash Equivalents	0	0.01	0.11	2.14	0.06	0.40	0.36	0.49	0.11	0.14
Others Assetsⓘ	0.02	0	2.99	3.30	0.79	4.88	6.37	18.31	11.26	13.87
Total Assets ⓘ	0.02	0.01	3.32	9.68	13.42	19.37	22.31	60.42	39.19	41.03

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Cash Flow From Operating Activity ⓘ	-0.08	1.98	1.05	0.52	1.71	-5.34	6.79
PBT ⓘ	0.35	1.27	3.53	4.30	16.91	-20.49	2.50
Adjustment ⓘ	0.01	0.63	1.34	1.10	3.46	2.50	2.16
Changes in Working Capital ⓘ	-0.43	0.5	-2.34	-3.14	-13.18	12.65	2.13
Tax Paid ⓘ	0	-0.42	-1.48	-1.64	-5.48	0	0
Cash Flow From Investing Activity ⓘ	0	-8.08	-0.67	-0.15	-22.03	5.22	-6.49
Capex	0	-8.08	-0.62	-0.15	-22.04	-0.04	-6.50
Net Investments	0	0	-0.05	0	0	0	0
Others ⓘ	0	0	0	0	0	5.26	0.01
Cash Flow From Financing Activityⓘ	2.10	4.03	-0.04	-0.47	20.45	-0.25	-0.27
Net Proceeds from Shares ⓘ	2.10	3.91	0	0	20.19	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	1.28	-0.25	-0.27
Interest Paid ⓘ	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	-0.43	-0.98	0	0
Others ⓘ	0	0.12	-0.04	-0.04	-0.04	0	0
Net Cash Flow ⓘ	2.02	-2.08	0.34	-0.10	0.13	-0.37	0.02

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Ratios
ROE (%)	N/A	N/A	1.91	8.12	10.25	19.62	20.32	36.25	-56.88	8.41
ROCE (%)	N/A	N/A	2.76	13.58	16.7	32.59	31.89	57.2	-56.03	9.52
Asset Turnover Ratio	0	0.67	0.2	1.03	4.02	1.96	1.76	1.46	0.73	0.64
PAT to CFO Conversion(x)	N/A	N/A	0	-0.23	2.44	0.48	0.19	0.16	N/A	3.06
Working Capital Days
Receivable Days	0	0	6	115	37	43	37	47	108	113
Inventory Days	0	0	184	0	0	54	48	34	35	9
Payable Days	0	0	68	132	28	75	81	49	42	128

Oceanaa Biotek Industries Ltd Stock News

Oceanaa Biotek Industries Ltd FAQs

What is the share price of Oceanaa Biotek?

Company share prices are keep on changing according to the market conditions. The closing price of Oceanaa Biotek on 23-May-2022 18:01 is ₹2.40.

What is the market cap of Oceanaa Biotek?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-May-2022 18:01 the market cap of Oceanaa Biotek stood at ₹3.26.

What is the P/E ratio of Oceanaa Biotek?

The latest P/E ratio of Oceanaa Biotek as of 23-May-2022 18:01 is 0.00.

What is the P/B ratio of Oceanaa Biotek?

The latest P/B ratio of Oceanaa Biotek as of 23-May-2022 18:01 is 0.12.

What is the 52-week high and low of Oceanaa Biotek?

The 52-week high of Oceanaa Biotek is ₹2.64 and the 52-week low is ₹2.40.

What is the TTM revenue of Oceanaa Biotek?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Oceanaa Biotek is ₹21.56 ( Cr.) .

About Oceanaa Biotek Industries Ltd

Oceanaa Biotek Industries was originally incorporated in 2005 and is based in Chennai, India. The company was formerly known as Oceanic Shelters Private Limited and changed its name to Oceanaa Biotek Industries Limited in May 2013. The company is a specialized food testing laboratory. Its focus is to offer the market a state-of-the-art laboratory that is certified and accredited to the highest standards. The companyâ€™s infrastructure is suited to test various categories of samples and matrices - majorly focusing on food testing. With a dedicated area of over 3,000 sqft, each section has dedicated equipment and staff. OBIL is capable of delivering testing solutions to the industry on time every time.

OBIL is an independent entity of the Oceanaa group of companies with interests in processing of marine products, vegetables and fruits - both for export sector and domestic retail sector. The company has a well equipped Research and Development (R&D) Lab infrastructure. Core focus is on ensuring complete safety by sampling and testing of each dayâ€™s production and to make sure that the seafood process adheres to the highest industry standards and meticulous product specification.

Business area of the company

The company is engaged in the trading of aquaculture products in India. The company also focuses on providing food analysis laboratory services that performs consumer food testing for food producers worldwide. In addition, it provides a range of courses aimed at training employees, students, and professionals in food processing and various related fields.